Stock Gumshoe Weekend Update

These newsletter ads that promise "government payouts" or "extra Social Security" or other "free" money probably generate more questions (and complaints) than even the "get rich quick" spiels about the next hot gold miner or biotech breakthrough/ And you can see why -- the target audience for investment newsletters is "folks in their 60s and 70s", for the most part, and the complexity of Social Security often makes people feel like they might be doing something wrong... so what's the story with this pitch from Personal Finance? Thinkolator answers here.

I continue to get lots of questions about the ads for Paul Mampilly's "#1 stock for 2018", so we shared that solution with you this week as well, dear readers -- the Irregulars saw this piece about five weeks ago, but now I've posted the teaser solution for everyone. What's this "Greatest Medical Breakthrough in History" stock? Just click here for that story.

We also took a gander at a "tiny biotech" that Jason Stutman says controls the gene-editing future in agriculture that will stave off famine... our explanation of that spiel is here.

And the Irregulars got a double-dose of commentary this week as well -- Dr. KSS shared his latest thoughts on Aptose here, and I posted my Friday File, as usual, with lots of big picture thoughts and portfolio updates to go along with another teaser solution about the "next Amazon."